Director, Global Oncology Market Access

Job Description

We are currently recruiting for a Director, Global Oncology Market Access, Lung Cancer

The Director will be developing and executing the market access & reimbursement strategies and tactics for lung cancer. The role will require a strong understanding of the oncology market, existing and emerging clinical data in lung cancer and shifting global payer environment, and experience in market access, pricing, health outcomes, and launch planning. This position will require outstanding cross functional leadership across access, commercial and Research & Development to conduct and update key market assessments, build the global plan for access and endorse the evidence generation plans for access. The role requires overall flawless execution of tactics to mitigate payers’ concerns on budgets and building robust payer value propositions.
 

Key responsibilities include and are not limited to the following:

• Overall responsibility for the development and adoption of the lung reimbursement startefy and tactics for lung cancer working closely with commercial asset/disease colleagues, and Value & Implementation (V&I) teams

• Coordinate input into lung V&I teams and provide the access related strategic inputs into the evidence plan generation.

• Coordinate with commercial colleagues to lead critical access pillars throughout commercial plans and senior management reviews, plan budgets and track commercial launch/competitive landscapes & clinical development progress.

• Provides access leadership and input on activities including launch sequencing, health authority interactions, launch readiness reviews, key customer engagement, payer research, patient segmentation  

• Engage with regional & local market access teams (especially US colleagues) to understand individual country market access & reimbursement needs ensuring these are included in asset Access strategies and V&I plans.

• Provide input on market access & reimbursement needs for new clinical trials being designed in lung cancer, including launch indication considerations, and indication expansions.

• Engage with regional & local teams, and coordinate with Value Evidence Sub-Team/Center for Observational and Real-world Evidence lead and Global Disease Leads (GDLs), to develop view on minimum level of clinical data needed from interim or final analyses to inform Go To File decision

• Lead payer market research to inform global asset access strategy and value dossier development

• Competitive reimbursement tracking to inform on the impact of competitor reimbursement positions and tactics, which impact access/pricing strategies.

• Works with pricing colleagues to provide strategy awareness and support materials

• Builds Low Middle Income Countries access opportunities and options

• Leverages data and digital to build tools and platforms for key insights and decision making

• Excellence in …